Absolute Bioavailability of Reslizumab in Healthy Subjects

Study Title

Absolute Bioavailability of Reslizumab in Healthy Subjects

Teva Identifier

C38072/1107

ClinicalTrials.gov Identifier

NCT01990443

Study Status

Completed

Trial Condition(s)

Absolute Bioavailability

Interventions

Drug: Reslizumab IV | Drug: Reslizumab SC

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations
disease icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 45 Years

Trial Duration

06/01/2013 - 03/01/2014

Phase

Phase 1

Study Type

Interventional